The Health Shadow Price, β c
(1) University of South Australia, Adelaide, Australia Abstract This chapter introduces five concepts central to this book. The opportunity cost of a strategy in an institutional setting is identified…
Conclusion
(1) University of South Australia, Adelaide, Australia Abstract The concluding chapter presents the guide for regulators to playing and winning the new drug reimbursement game. The results from the…
The Clinical Value of Innovation
(1) University of South Australia, Adelaide, Australia Abstract The term “innovation” is used in a number of different ways in pharmaceutical regulation processes. In this chapter I address the…
Reframing the Political Economy of New Drugs
(1) University of South Australia, Adelaide, Australia Abstract The first rule of the new drug reimbursement game is to recognise it is a game and that the regulator makes…
The Shadow Price, λ
(1) University of South Australia, Adelaide, Australia Abstract In countries such as Australia, the UK and Canada, regulators are required to select a decision threshold that is a signal…
